Daniele Di Stefano

Showing 1-4 of 4 articles

Interventions for valvular disease

Impact of horizontal aorta on procedural and clinical outcomes in second-generation transcatheter aortic valve implantation

Di Stefano D, Colombo A, Mangieri A, Gallone G, Tzanis G, Laricchia A, Baldetti L, Palmisano A, Esposito A, Gallo F, Latib A, Montorfano M, Giannini F

October 4, 2019 | 10.4244/EIJ-D-19-00455

Interventions for valvular disease

Four-year durability of clinical and haemodynamic outcomes of transcatheter aortic valve implantation with the self-expanding CoreValve

Gulino S, Barbanti M, Deste W, Imme S, Aruta P, Bottari V, Benvenuto E, Tamburino C, Di Landro A, Liberto D, Santonoceto L, Sicuso R, Di Stefano D, Todaro D, Di Simone E, Indelicato A, Giannazzo D, Sgroi C, Tamburino C

October 10, 2016 | 10.4244/EIJY15M10_08

Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation

Barbanti M, Capranzano P, Ohno Y, Gulino S, Sgroi C, Imme S, Tamburino Cl, Cannata S, Patane M, Di Stefano D, Todaro D, Di Simone E, Deste W, Gargiulo G, Capodanno D, Grasso C, Tamburino C

October 20, 2015 | 10.4244/EIJV11I6A137

Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies

Capodanno D, Milazzo G, Vitale L, Di Stefano D, Di Salvo M, Grasso C, Tamburino C

March 20, 2014 | 10.4244/EIJV9I11A225

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: Transcatheter treatment of multivalvular heart disease

Cardioband after placement of 17 screws before and after

Balancing risks and benefits of LM revascularisation strategies in CKD patients

Gennaro Giustino

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Contained annulus ruptures – the price to pay for optimal haemodynamic results?

Fabian Nietlispach

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke